Manhattan Bridge Capital Inc.  

(Public, NASDAQ:LOAN)   Watch this stock  
Find more results for LOAN
-0.03 (-1.39%)
Apr 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.84 - 1.92
52 week 1.20 - 2.30
Open 1.92
Vol / Avg. 2,557.00/9,898.00
Mkt cap 7.83M
P/E 14.47
Div/yield 0.02/4.35
EPS 0.13
Shares 4.26M
Beta 0.29
Inst. own 5%

Key stats and ratios

Q3 (Sep '13) 2012
Net profit margin 33.15% 21.40%
Operating margin 50.09% 36.59%
EBITD margin - 52.08%
Return on average assets 4.91% 3.18%
Return on average equity 8.85% 4.69%
Employees 3 -
CDP Score - -


Suite 205, 60 Cutter Mill Rd
United States - Map
+1-516-4443400 (Phone)
+1-516-4443404 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Manhattan Bridge Capital, Inc. (MBC), through its wholly owned subsidiaries, offer short-term, secured, nonbanking loans to real estate investors to fund their acquisition and construction of properties located in the New York Metropolitan area. The loans are principally secured by collateral consisting of real estate and, generally, accompanied by personal guarantees from the principals of the businesses. Its subsidiaries include DAG Funding Solutions, Inc. and MBC Funding I, Inc. The Company generally grants loans for a term of one year. Most of the loans provide for receipt of interest only during the term of the loan and a balloon payment at the end of the term.

Officers and directors

Assaf N. Ran Chairman of the Board, President, Chief Executive Officer, Founder
Age: 47
Bio & Compensation  - Reuters
Vanessa Kao Chief Financial Officer, Vice President, Treasurer, Secretary
Age: 35
Bio & Compensation  - Reuters
Mark Alhadeff Director
Age: 49
Bio & Compensation  - Reuters
Lyron L. Bentovim Independent Director
Age: 44
Bio & Compensation  - Reuters
Eran Goldshmit Independent Director
Age: 46
Bio & Compensation  - Reuters
Michael J. Jackson Independent Director
Age: 48
Bio & Compensation  - Reuters